PATH
D. Scott LaMontagne, PhD, MPH, FRSPH, CS, is an epidemiologist and project director for HPV vaccines and country preparedness teams at PATH. He leads a global team of vaccine delivery experts assisting more than twenty countries in sub-Saharan Africa and Asia to conduct and evaluation HPV vaccination programs. He has authored and co-authored numerous papers on the clinical and operational aspects of HPV vaccine delivery in developing countries and is a recognized expert in HPV vaccine delivery and evaluation in low-resource settings. Dr. LaMontagne has over 20 years of experience in infectious disease surveillance, operations and implementation research, public health program implementation, monitoring and evaluation, and project management for government and nongovernmental agencies at local, state, and national levels in developed and developing countries. He is a specialist in surveillance and epidemiology of human papillomavirus, Chlamydia trachomatis, tuberculosis, and sexually transmitted infections. Dr. LaMontagne has a PhD from Middlesex University in London, England, and a master’s degree in public health from Yale University.